圣达生物
(603079)
| 流通市值：29.00亿 | | | 总市值：29.00亿 |
| 流通股本：1.71亿 | | | 总股本：1.71亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 203,225,651.02 | 827,401,959.68 | 608,870,278.32 | 384,474,783.09 |
| 营业收入 | 203,225,651.02 | 827,401,959.68 | 608,870,278.32 | 384,474,783.09 |
| 二、营业总成本 | 174,454,492.13 | 775,052,391.23 | 577,385,792.61 | 364,482,739.87 |
| 营业成本 | 144,500,426.11 | 651,452,036.05 | 485,917,821.02 | 307,567,509.1 |
| 税金及附加 | 2,634,795.27 | 11,105,308.87 | 7,426,983.96 | 4,780,786.68 |
| 销售费用 | 2,668,964.54 | 14,645,144.2 | 10,092,998.05 | 6,484,170.01 |
| 管理费用 | 14,864,798.75 | 63,843,516.05 | 49,669,221.61 | 32,220,985.38 |
| 研发费用 | 10,162,625.24 | 43,762,465.09 | 29,025,818.97 | 18,806,646.7 |
| 财务费用 | -377,117.78 | -9,756,079.03 | -4,747,051 | -5,377,358 |
| 其中:利息费用 | 250,833.34 | 2,076,164.12 | 1,099,956.42 | 848,173.63 |
| 其中:利息收入 | 644,875 | 7,951,083.85 | 4,109,259.65 | 3,179,259 |
| 加:公允价值变动收益 | -756.6 | 1,210.56 | 2,068.04 | 1,109.68 |
| 加:投资收益 | 449,777.4 | 723,379.08 | 3,015,295.08 | 2,929,906.19 |
| 资产处置收益 | -86,177.7 | 145,968.82 | - | - |
| 资产减值损失(新) | -3,243,969.71 | -10,643,054.89 | -5,972,851.85 | -5,911,600.85 |
| 信用减值损失(新) | -627,119.21 | -5,462,103.38 | -6,655,326.71 | -4,295,392.98 |
| 其他收益 | 2,370,433.86 | 9,451,253.94 | 6,350,545.46 | 4,635,410.46 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 27,633,346.93 | 46,566,222.58 | 28,224,215.73 | 17,351,475.72 |
| 加:营业外收入 | 104,456.49 | 11,171,213.82 | 11,170,564.99 | 11,016,563.16 |
| 减:营业外支出 | 1,420.42 | 8,652,161.83 | 4,187,764.43 | 4,175,051.24 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 27,736,383 | 49,085,274.57 | 35,207,016.29 | 24,192,987.64 |
| 减:所得税费用 | 4,317,471.64 | 11,827,625.68 | 7,797,813.78 | 4,714,752.03 |
| 六、净利润 | 23,418,911.36 | 37,257,648.89 | 27,409,202.51 | 19,478,235.61 |
| 持续经营净利润 | 23,418,911.36 | 37,257,648.89 | 27,409,202.51 | 19,478,235.61 |
| 归属于母公司股东的净利润 | 21,709,484.85 | 29,424,490.05 | 21,679,027.87 | 16,494,835.49 |
| 少数股东损益 | 1,709,426.51 | 7,833,158.84 | 5,730,174.64 | 2,983,400.12 |
| (一)基本每股收益 | 0.13 | 0.17 | 0.13 | 0.1 |
| (二)稀释每股收益 | 0.13 | 0.17 | 0.13 | 0.1 |
| 九、综合收益总额 | 23,418,911.36 | 37,257,648.89 | 27,409,202.51 | 19,478,235.61 |
| 归属于母公司股东的综合收益总额 | 21,709,484.85 | 29,424,490.05 | 21,679,027.87 | 16,494,835.49 |
| 归属于少数股东的综合收益总额 | 1,709,426.51 | 7,833,158.84 | 5,730,174.64 | 2,983,400.12 |
| 公告日期 | 2025-04-28 | 2025-04-28 | 2024-10-26 | 2024-08-23 |
| 审计意见(境内) | | 标准无保留意见 | | |